Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lokich

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Cancer Treatment Reports|September 1, 1981
Phase I study of VP-16-213 (Etoposide) administered as a continuous 5-day infusionJ Lokich, J Corkery
Cancer|January 15, 1990
Bilateral breast cancer after cured Hodgkin's diseaseN Anderson, J Lokich
Cancer Investigation|June 17, 1998
Ki-1 anaplastic large-cell lymphoma in the differential diagnosis of unknown primary cancerJ Lokich, B Sherburne
Cancer Investigation|January 1, 1995
Infusional cancer chemotherapy: historical evolution and future development at the Cancer Center of BostonJ Lokich, N Anderson
Cancer|August 15, 1992
Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisonsN Anderson, J Lokich
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agentsJ Lokich, N Anderson
Cancer|November 1, 1983
Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancyJ J Lokich, B Becker
Oncology (Williston Park, N.Y.)|May 1, 1994
Cancer chemotherapy and infusional schedulingN Anderson, J J Lokich
Cancer|November 15, 1985
A phase I and pharmacology study of continuous-infusion low-dose methotrexate administrationJ J Lokich, G Curt
Cancer Drug Delivery|January 1, 1984
Phase-I study of continuous infusion cyclophosphamide for protracted durations: a preliminary reportJ J Lokich, A Bothe
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Cancer Treatment Reports|September 1, 1981
Phase I study of VP-16-213 (Etoposide) administered as a continuous 5-day infusionJ Lokich, J Corkery
Cancer|January 15, 1990
Bilateral breast cancer after cured Hodgkin's diseaseN Anderson, J Lokich
Cancer Investigation|June 17, 1998
Ki-1 anaplastic large-cell lymphoma in the differential diagnosis of unknown primary cancerJ Lokich, B Sherburne
Cancer Investigation|January 1, 1995
Infusional cancer chemotherapy: historical evolution and future development at the Cancer Center of BostonJ Lokich, N Anderson
Cancer|August 15, 1992
Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisonsN Anderson, J Lokich
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agentsJ Lokich, N Anderson
Cancer|November 1, 1983
Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancyJ J Lokich, B Becker
Oncology (Williston Park, N.Y.)|May 1, 1994
Cancer chemotherapy and infusional schedulingN Anderson, J J Lokich
Cancer|November 15, 1985
A phase I and pharmacology study of continuous-infusion low-dose methotrexate administrationJ J Lokich, G Curt
Cancer Drug Delivery|January 1, 1984
Phase-I study of continuous infusion cyclophosphamide for protracted durations: a preliminary reportJ J Lokich, A Bothe
Pageof 16